Breast Cancer: Iria's Survivor Story
This breast cancer diagnosis at a glance
- Sex
- Female
- Treatment
- chemotherapy and a clinical trial
- Outcome
- Survivorship / Completed Treatment
Treatment course, step by step
- Breast cancer diagnosed in 2013 after mammography at age 34
- clinical trial with experimental therapy offered soon after diagnosis
- chemotherapy began after the first month of workup and waiting
- 10 months of treatment overall.
What happened, in summary
Iria was 34 when she decided to stop avoiding breast screening. Her mother had developed breast cancer before age 40, and Iria had long lived with fear that it could happen to her too. In 2013, while working in health insurance, a conversation with a colleague who had a gynecology appointment pushed her to schedule a mammogram. The diagnosis brought an intense urge to move quickly and remove the tumor, but it also brought trusted doctors into her life at Hospital Gregorio Marañón. Her gynecologist and oncologist helped her feel that she was making the right decisions. Iria began using a special notebook to track everything about appointments, treatment, and the disease. Soon after diagnosis, she was offered a clinical trial with experimental therapy. It was not easy to understand, but she joined because she trusted her doctors and wanted her decision to help future patients. The hardest period was the first month, before chemotherapy began. After that came 10 months of treatment, emotionally like a roller coaster. Her mother traveled to Madrid to accompany her during cycles, while coworkers, music, dancing at home, and sewing helped her stay steady through treatment and recovery.
Where this story comes from
This is a lay summary of an account first published by Roche España Historias. Read the original in full
How we source and attribute stories Accuracy and limitations
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer